The acute effects of intravenous frusemide on the renal kallikrein kinin system in man: Relationship to dose

Immunopharmacology

Volumn 32, Issue 1-3, 1996, Pages 122-124

  Bicknell, Colin ^a   Campbell, Sara ^a   Waller, Derek ^a   Albano, Janet ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Frusemide; Kinin; Man; Urinary kallikrein

Indexed keywords

FUROSEMIDE; KALLIKREIN; KININ; MESSENGER RNA;

ADULT; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIURETIC ACTIVITY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SINGLE BLIND PROCEDURE; URINARY EXCRETION;

EID: 0029974241     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/0162-3109(95)00071-2     Document Type: Conference Paper

References (16)

1. Abe K, Irokawa N, Yasujima M, Seino M Chiba S, Sakurai Y, Yoshinga K, Sato T. The kallikrein-kinin system and prostaglandins in the kidney, their relationship to furosemide-induced diuresis and the renin-angiotensin -aldosterone system in man. Circ. Res. 1978; 43: 254-260.
2. Bascands JL, Girolami JP, Pecher C, Cabos G, Moatti JP, Suc JM, Manuel Y. Short lasting increase in urinary specific kallikrein activity during long term administration of furosemide. Agents Actions 1987; 22: 302-309.
3. Bhoola KD, Figueroa CD, Worthy K. Bioregulation of Kinins: Kallikreins, Kininogens and Kininases. Am. Soc. Pharmacol. Exp. Ther. 1992; 44: 1-80.
4. Bonner G, Beck D, Deeg M, Marin-Grez M, Schwertschlag U, Gross F. Interelation between renal kallikrein and diuresis in rats. Adv. Exp. Med. Biol. 1983; 156: 949-960.
5. Campbell SK, Marshall KG, Millar JGB, Venkat Raman G, Albano JDM. Biological assay for tissue kallikrein: comparison with the synthetic substrate S2266. Agents Actions 1992; 38; 159-165.
6. Chennavasin P, Seiwell R, Brater DC. Pharmacokinetic-dynamic analysis of the indomethacin-frusemide interaction in man. J. Pharmacol. Exp. Ther. 1980; 215: 77-81.
7. Mackay IG, Watson ML, Nath KA, Cumming AD, Muir AL. Urinary kallikrein and prostaglandin response to frusemide in mild hypertension. Contr. Nephrol. 1984; 41: 160-162.
8. Ohman KP and Karlsberg BE. Plasma and tissue kallikrein-kinin systems during acute administration of frusemide in normotensive and hypertensive humans. Clin. Sci. 1991; 81: 305-311.
9. Overlack A, Stumpe KO, Muller HM, Kolloch R, Higuchi M. Interactions of diuretics with the renal kallikrein-kinin and protaglandin systems. Klin. Wochenscher. 1982; 60:1223-1228.
10. Penchow JD and Coghlan JP. Frusemide alters the distribution of kallikrein gene expression in kidney of mice. J. Hypertension 1994;12 (Suppl.3): 887.
11. Schlatter E, Greger R, Weidtke C. Effect of high ceiling diuretics on active salt transport in the cortical thick ascending limb of Henle's loop of rabbit kidney: Correlation of chemical structure and inhibitory potency. Pflug. Arch. 1983; 396: 210-217.
12. Toussaint C, Masselink A, Gentges A Warmbach G Bonner G. Interference of different ACE-inhibitors with the diuretic action of frusemide and hydrochlorothiazide. Klin. Wochenschr. 1989; 67: 1138-1146.
13. Waller DG, Thakrar PM, Campbell SK. Amiloride, frusemide and urinary kallikrein excretion. Arch. Pharmacodyn. Ther. 1987; 290: 145-150.
14. Waller DG, Bhatia SS, Campbell SK, Albano JDM, Millar JGB. Active and inactive urinary kallikrein excretion in man: effects of diuresis and antidiuresis. Clin. Sci. 1990; 79: 117-121.
15. Weinberg MS, Azar P, Trebbin WM, Solomon RJ. The role of urinary kininogen in the regulation of kinin generation. Kidney Inter. 1985; 28: 975-981.
16. Zschiedrich H, Fleckenstein P, Geiger R, Fink E, Sinterhauf K, Philpp TH, Distler A, Wolff HP. Urinary kallikrein in normotensive subjects and in patients with essential hypertension. Clin. Sci. 1979; 57: 247-250.